These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16931453)

  • 21. Leptin in congenital and HIV-associated lipodystrophy.
    Tsoukas MA; Farr OM; Mantzoros CS
    Metabolism; 2015 Jan; 64(1):47-59. PubMed ID: 25267014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term efficacy of leptin replacement in patients with generalized lipodystrophy.
    Javor ED; Cochran EK; Musso C; Young JR; Depaoli AM; Gorden P
    Diabetes; 2005 Jul; 54(7):1994-2002. PubMed ID: 15983199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adipose tissue transplantation ameliorates lipodystrophy-associated metabolic disorders in seipin-deficient mice.
    Wang H; Xu PF; Li JY; Liu XJ; Wu XY; Xu F; Xie BC; Huang XM; Zhou ZH; Kayoumu A; Liu G; Huang W
    Am J Physiol Endocrinol Metab; 2019 Jan; 316(1):E54-E62. PubMed ID: 30457912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health risks of lipodystrophy and abdominal fat accumulation: therapeutic possibilities with leptin and human growth hormone.
    Van Gaal LF; Mertens IL; Abrams PJ
    Growth Horm IGF Res; 2003 Aug; 13 Suppl A():S4-9. PubMed ID: 12914718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leptin's role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals.
    Moon HS; Dalamaga M; Kim SY; Polyzos SA; Hamnvik OP; Magkos F; Paruthi J; Mantzoros CS
    Endocr Rev; 2013 Jun; 34(3):377-412. PubMed ID: 23475416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in body composition in patients with severe lipodystrophy after leptin replacement therapy.
    Moran SA; Patten N; Young JR; Cochran E; Sebring N; Reynolds J; Premkumar A; Depaoli AM; Skarulis MC; Oral EA; Gorden P
    Metabolism; 2004 Apr; 53(4):513-9. PubMed ID: 15045701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of leptin-replacement therapy and possible mechanisms of leptin actions in patients with generalized lipodystrophy.
    Ebihara K; Kusakabe T; Hirata M; Masuzaki H; Miyanaga F; Kobayashi N; Tanaka T; Chusho H; Miyazawa T; Hayashi T; Hosoda K; Ogawa Y; DePaoli AM; Fukushima M; Nakao K
    J Clin Endocrinol Metab; 2007 Feb; 92(2):532-41. PubMed ID: 17118991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metreleptin and generalized lipodystrophy and evolving therapeutic perspectives.
    Tchang BG; Shukla AP; Aronne LJ
    Expert Opin Biol Ther; 2015 Jul; 15(7):1061-75. PubMed ID: 26063386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leptin in relation to the lipodystrophy-associated metabolic syndrome.
    Mantzoros CS
    Diabetes Metab J; 2012 Jun; 36(3):181-9. PubMed ID: 22737657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preclinical, randomized phase 1, and compassionate use evaluation of REGN4461, a leptin receptor agonist antibody for leptin deficiency.
    Altarejos JY; Pangilinan J; Podgrabinska S; Akinci B; Foss-Freitas M; Neidert AH; Ray Y; Zheng W; Kim S; Kamat V; Huang M; Min S; Mastaitis J; Dominguez-Gutierrez G; Kim JH; Stevis P; Huang T; Zambrowicz B; Olson WC; Godin S; Bradley E; Gewitz AD; Baker M; Hench R; Davenport MS; Chenevert TL; DiPaola F; Yancopoulos GD; Murphy AJ; Herman GA; Musser BJ; Dansky H; Harp J; Gromada J; Sleeman MW; Oral EA; Olenchock BA
    Sci Transl Med; 2023 Nov; 15(723):eadd4897. PubMed ID: 37992152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amylin improves the effect of leptin on insulin sensitivity in leptin-resistant diet-induced obese mice.
    Kusakabe T; Ebihara K; Sakai T; Miyamoto L; Aotani D; Yamamoto Y; Yamamoto-Kataoka S; Aizawa-Abe M; Fujikura J; Hosoda K; Nakao K
    Am J Physiol Endocrinol Metab; 2012 Apr; 302(8):E924-31. PubMed ID: 22275759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metreleptin Treatment in Patients with Non-HIV Associated Lipodystrophy.
    Akinci G; Akinci B
    Recent Pat Endocr Metab Immune Drug Discov; 2015; 9(2):74-8. PubMed ID: 26556498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rationale for leptin-replacement therapy for severe lipodystrophy.
    Oral EA; Chan JL
    Endocr Pract; 2010; 16(2):324-33. PubMed ID: 20061299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leptin replacement therapy does not improve the abnormal lipid kinetics of hypoleptinemic patients with HIV-associated lipodystrophy syndrome.
    Sekhar RV; Jahoor F; Iyer D; Guthikonda A; Paranilam J; Elhaj F; Coraza I; Balasubramanyam A
    Metabolism; 2012 Oct; 61(10):1395-403. PubMed ID: 22542724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid improvement of hepatic steatosis after initiation of leptin substitution in a leptin-deficient girl.
    von Schnurbein J; Heni M; Moss A; Nagel SA; Machann J; Muehleder H; Debatin KM; Farooqi S; Wabitsch M
    Horm Res Paediatr; 2013; 79(5):310-7. PubMed ID: 23651953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of leptin replacement therapy on pancreatic β-cell function in patients with lipodystrophy.
    Muniyappa R; Brown RJ; Mari A; Joseph J; Warren MA; Cochran EK; Skarulis MC; Gorden P
    Diabetes Care; 2014 Apr; 37(4):1101-7. PubMed ID: 24496806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leptin Substitution in Patients With Lipodystrophy: Neural Correlates for Long-term Success in the Normalization of Eating Behavior.
    Schlögl H; Müller K; Horstmann A; Miehle K; Püschel J; Villringer A; Pleger B; Stumvoll M; Fasshauer M
    Diabetes; 2016 Aug; 65(8):2179-86. PubMed ID: 27207511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of leptin replacement on pituitary hormone regulation in patients with severe lipodystrophy.
    Oral EA; Ruiz E; Andewelt A; Sebring N; Wagner AJ; Depaoli AM; Gorden P
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3110-7. PubMed ID: 12107209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metreleptin worked in a diabetic woman with a history of hematopoietic stem cell transplantation (HSCT) during infancy: further support for the concept of 'HSCT-associated lipodystrophy'.
    Adachi M; Muroya K; Hanakawa J; Asakura Y
    Endocr J; 2021 Apr; 68(4):399-407. PubMed ID: 33229817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy.
    Javor ED; Ghany MG; Cochran EK; Oral EA; DePaoli AM; Premkumar A; Kleiner DE; Gorden P
    Hepatology; 2005 Apr; 41(4):753-60. PubMed ID: 15791619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.